Variational AI

State-of-the-art generative #machinelearning for #drugdiscovery

[Variational AI @VariationalAI]

Event details: https://t.co/Q5FDItbk93

[Variational AI @VariationalAI]

With Enki™ 4, our #GenerativeAI now designs beyond small molecules, and can be applied to proximity-based therapeutics: #PROTACs, #MolecularGlues, #Degraders, #ADC payloads. Meet us at #BIO2026 in San Diego. Request on the platform or [email protected]
#DrugDiscovery #AIDD

[Variational AI @VariationalAI]

We’re (still) growing at @VariationalAI 🚀
Come work at the intersection of #AI and #chemistry to help #pharma & #biotech teams discover innovative, drug-like #SmallMolecules more efficiently.
👉 https://t.co/Wxcm9GZbIU

#Hiring #ML #Jobs #CompChem

[Variational AI @VariationalAI]

Variational AI will be at #BIO2026, San Diego, June 22-25.
Scoping an early-stage program where #GenerativeAI could speed up multi-property optimization? Let's talk!
Book a meeting using the platform or via email at [email protected]
https://t.co/uvjhQgVXkj
#AIDD #GenAIinPharma

[Variational AI @VariationalAI]

Enki 4 launched last month with 760 pre-trained drug targets. We're now at 873!
Check if yours is covered and explore starting a program: https://t.co/niAzC8AjB5
#AIDD #DrugDiscovery #AIinPharma #GenerativeAI #SmallMolecules #VariationalAI #GenAIinPharma

[Variational AI @VariationalAI]

@VariationalAI is hiring a Chemical Data Scientist! Curate datasets across potency, ADMET, gene expression, etc.... Build featurizations that feed Enki™. Vancouver or remote in Canada. https://t.co/TNlqrnMxty #AIDD #Hiring #Cheminformatics #DataScience

[Variational AI @VariationalAI]

@VariationalAI and 3C Therapeutics are launching a research collaboration to design next-generation Degrader Antibody Conjugates (DACs), with support from Innovate BC's Integrated Marketplace program.
Full release 👉
https://t.co/6VowrtDX6q

[Variational AI @VariationalAI]

"The new unit economics of drug discovery" at #WebSummit yesterday: Handol Kim, Ricardo Baptista Leite (HealthAI), and Jennifer Strong (SHIFT Podcast) on how AI shifts pharma from massive libraries to targeted molecular design, and what regulators need to do next. #AIDD

[Variational AI @VariationalAI]

At #WebSummit Vancouver this week? Find us at Booth G1-09 today only to talk about our generative AI platform for early-stage small molecule discovery. #GenerativeAI #AIDD

[Variational AI @VariationalAI]

Variational AI is hiring across ML, Chemistry and Project Mgt. Vancouver or remote in N Am. Real science! https://t.co/NW0gAdviNx
#AIDD #Hiring #NowHiring #DrugDiscovery #ComputationalChemistry #MachineLearning

[Variational AI @VariationalAI]

Today at Boston PBSS, our CTO Jason Rolfe is speaking about generative molecular design, and specifically how starting from better chemical space leads to better leads with fewer DMTA cycles. How it works? https://t.co/ooVUmRXrVD
#AIDD #DrugDiscovery #PBSS

[Variational AI @VariationalAI]

Heading to @WebSummit Vancouver. Meet us at our booth on May 12, and catch Handol Kim on the AI Summit stage on May 13 for "The new unit economics of drug discovery." https://t.co/tJE9bVXjDX #GenerativeAI #WebSummitVancouver #AIDD #DrugDiscovery

[Variational AI @VariationalAI]

6 open roles at Variational AI across ML, computational chemistry, and drug discovery project management. Vancouver or Remote in N Am. Full-time. Real science! 🚀
https://t.co/Lia5MoSMyY
#AIDD #Hiring #NowHiring #DrugDiscovery #ComputationalChemistry #MachineLearning

[Variational AI @VariationalAI]

Most #DrugDiscovery programs optimize within known chemical space. What happens when you can explore beyond it? Jason Rolfe makes the case at #PBSS Cambridge, on April 28. 👉 Interested? Register here: https://t.co/XwaUfszX1T
#AIDD #GenerativeAI

[Variational AI @VariationalAI]

Today at ALL IN Talks West, Variational AI CEO Handol Kim speaks on closing the gap between #AI research and real-world impact, using #DrugDiscovery as the proving ground.
🔗 https://t.co/m9nvbjvCOj
#GenerativeAI #AIDD

[Variational AI @VariationalAI]

DDC 2026, San Diego, this week. Find Brian Atwood from @VariationalAI to discuss how #GenerativeAI fits into your early #SmallMolecule discovery workflow.
🔗 https://t.co/SgwPMSVSbT
or ✉️ [email protected]
#DDC2026 #AIDD #GenAIinPharma

[Variational AI @VariationalAI]

"Our goal is to eliminate hit ID and hit-to-lead, generating molecules ready to go directly into lead optimization." — Handol Kim, Co-Founder & CEO
Enki™ 4 is live - https://t.co/pD5jo5NGui

#AIDD #DrugDiscovery #GenerativeAI #GenAIinPharma #Enki4 #VariationalAI

[Variational AI @VariationalAI]

Handol Kim opens the UBC Faculty of Medicine Transforming Health Symposium today as the keynote speaker! 🎙️
https://t.co/xeonRuD9Ww
#AIDD #DrugDiscovery #GenAIinPharma #VariationalAI

[Variational AI @VariationalAI]

Visit the Enki webpage to access the list of targets available - https://t.co/9ShSoWeT1V

[Variational AI @VariationalAI]

We just released Enki™ 4 🚀
760 pre-trained targets, 12+ target classes, and new coverage for degraders, PROTACs, and ADC payloads. Our Goal? Eliminating hit ID and hit-to-lead! https://t.co/M02youUE1U
#Enki4 #AIDD #GenerativeAI #VariationalAI #GenAIinPharma #DrugDiscovery